The EU medical device regulation has created a new category known as 'Aesthetic Devices'. These are defined as devices “without and intended medical purpose”.
The EU medical device regulation has created a new category known as 'Aesthetic Devices'. These are defined as devices “without and intended medical purpose”.
At a review of the IDEA Project, the fragrance industry reaffirmed its commitment to finding alternatives to animal testing in assessing skin sensitizers.
The 9th edition of the SCCS' safety assessment and guidance outlines practices for safety assessors and performing tests on cosmetics products in the EU.
REACH data-sharing principles define terms of transparency, non-discrimination, and fairness for chemical substance registration.
Scientific Committee on Consumer Safety revise opinion on o-Phenylphenol and its concentration limit in cosmetics on the EU market.
The RAPEX database was created as an alert system for EU product compliance issues. Learn more about how it works and its role in general EU market vigilance.
Understanding the definition of a medical device as outlined by European Medical Device Directive 93/42/EEC. Talk to Obelis for more EU compliance information.
Formaldehyde, classified as a category 1B carcinogen, will be banned from use in EU cosmetics from January 2016 under cosmetics regulation 1223/2009/EC.
The Community Rolling Action Plan provides processes for substance evaluation and health/environmental risk clarification for cosmetics products in Europe.
ISO 16128 provides technical definitions and criteria for natural and organic ingredients in cosmetic products.